kabutan

Chiome Bioscience Inc., July-September (3Q) Net Income Loss Widens

Tue Nov 12, 2024 4:00 pm JST Earnings

4583 Chiome Bioscience Inc. 【J-GAAP】

Earnings Report

Chiome Bioscience Inc. <4583> [TSE-G] announced its financial results after the market closed on November 12th (16:00). The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending December 2024 (January to September) was a reduced loss of 915 million yen (compared to a loss of 918 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the net loss expanded to a loss of 352 million yen (compared to a loss of 255 million yen in the same period last year). The operating profit/loss margin drastically worsened from -148.2% in the same period last year to -213.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 433 -1,039 -1,029 -1,027 -23.9 ー Nov 14, 2022 J-GAAP
Jan - Sep, 2023 524 -905 -916 -918 -18.8 ー Nov 14, 2023 J-GAAP
Jan - Sep, 2024 422 -920 -914 -915 -16.3 ー Nov 12, 2024 J-GAAP
YoY -19.5% -1.7% +0.2% +0.3% +13.6%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 Prev 457 ー ー ー － 0 Aug 13, 2024 J-GAAP
Jul - Dec, 2024 New 337 ー ー ー － 0 Nov 12, 2024 J-GAAP
Revision Rate -26.3% － － － －

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Prev 720 ー ー ー － 0 Feb 13, 2024 J-GAAP
Dec, 2024 New 600 ー ー ー － 0 Nov 12, 2024 J-GAAP
Revision Rate -16.7% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 324 -546 -555 -557 -11.2 0 Feb 13, 2024 J-GAAP
Jul - Dec, 2024 Guidance 337 ー ー ー － 0 Nov 12, 2024 J-GAAP
YoY +4.0% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 630 -1,258 -1,243 -1,242 -28.3 0 Feb 14, 2023 J-GAAP
Dec, 2023 682 -1,205 -1,217 -1,220 -24.6 0 Feb 13, 2024 J-GAAP
Dec, 2024 Guidance 600 ー ー ー － 0 Nov 12, 2024 J-GAAP
YoY -12.0% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 166 -246 -254 -255 -5.2 -148.2 Nov 14, 2023 J-GAAP
Oct - Dec, 2023 158 -300 -301 -302 -6.1 -189.9 Feb 13, 2024 J-GAAP
Jan - Mar, 2024 129 -322 -303 -304 -5.6 -249.6 May 14, 2024 J-GAAP
Apr - Jun, 2024 134 -259 -260 -259 -4.7 -193.3 Aug 13, 2024 J-GAAP
Jul - Sep, 2024 159 -339 -351 -352 -6.3 -213.2 Nov 12, 2024 J-GAAP
YoY -4.2% -37.8% -38.2% -38.0% -19.7%

Related Articles